BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,037,900 | -32.9% | 379,090 | -15.6% | 17.25% | +9.7% |
| Q2 2023 | $28,375,978 | +1.3% | 448,987 | -27.9% | 15.72% | +35.4% |
| Q1 2023 | $28,021,077 | +9.9% | 622,829 | +7.1% | 11.61% | +21.3% |
| Q4 2022 | $25,487,256 | -26.2% | 581,768 | +11.0% | 9.57% | -23.1% |
| Q3 2022 | $34,544,000 | -4.6% | 524,268 | -26.8% | 12.45% | +0.8% |
| Q2 2022 | $36,192,000 | -27.5% | 716,539 | -8.3% | 12.35% | +68.3% |
| Q1 2022 | $49,925,000 | -27.8% | 781,539 | +21.1% | 7.34% | -6.4% |
| Q4 2021 | $69,144,000 | +28.9% | 645,539 | +23.7% | 7.84% | -19.5% |
| Q3 2021 | $53,633,000 | +35.9% | 521,673 | +16.3% | 9.74% | -5.0% |
| Q2 2021 | $39,451,000 | -4.1% | 448,512 | +6.0% | 10.25% | +37.9% |
| Q1 2021 | $41,129,000 | -3.5% | 423,012 | +11.3% | 7.43% | -16.1% |
| Q4 2020 | $42,618,000 | +19.2% | 380,012 | -1.5% | 8.86% | +134.0% |
| Q3 2020 | $35,757,000 | +45.5% | 385,727 | +22.4% | 3.78% | -23.6% |
| Q2 2020 | $24,572,000 | +902.5% | 315,029 | +928.9% | 4.96% | +356.7% |
| Q1 2019 | $2,451,000 | – | 30,618 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |